Asha’s vision is to bring hope in the lives of patients, by enhancing the bioavailability of new drugs, helping them get to the market faster and reducing drug development costs.
We work with our clients through the solid form screening and selection process and develop optimized crystallization processes.
Our innovative and efficient proprietary workflows, and state of the art analytical instruments, help discover novel solid forms (polymorphs, salts and cocrystals) of pharmaceutical molecules, and enhance bioavailability of poorly soluble drugs.
We aspire to be the best in class solid form research company in the world.
Discovering novel solid forms of drug molecules is an essential part of drug development and has significant regulatory, legal, financial and medical implications.
This highly specialized work is frequently outsourced. Outsourcing providers need to design scientifically rigorous and efficient experiments, to generate quality data, and reduce time and labor requirements. They also need to help clients select the optimal solid form for development.
Scalability of the forms and crystallization processes, discovered and developed at this stage, is a key aspect which is often overlooked.
Smaller pharma companies with limited resources, often skip these critical tasks, or can only afford substandard data, which leads to significant costs further downstream, or leads to promising drug molecules not making it to market.
Asha’s innovative and efficient workflows, have been built using the latest advances in solid form science, and are easily customizable, based on the drug molecule and the drug development timeline (Phase-Appropriate).
Our crystallization focused lab in San Diego, has multiple state of the art analytical instruments, which help us fully characterize the solid state of a molecule.
We understand that our clients are often dealing with short timelines, and we use a risk based approach to discover and select polymorphs, salts and cocrystals.
We are experts in finding the optimal solution to a solid form problem, taking into account the time and resources available.
Our Chemical Engineering expertise, helps us keep scalability of our solid forms and processes in mind, even at the screening stage, and helps us develop optimized crystallization processes.
A particular focus, is generating high quality scientific data, for smaller companies, at a reasonable cost, and enhancing the bioavailability of poorly soluble molecules.